Details of issuance or disposal
Exercise of the 15th stock acquisition rights issued through a third-party allotment (with an option to revise the exercise price)
90,500 new shares (32,500 shares on 19 March, 38,000 shares on 23 March and 20,000 shares on 24 March)
90,500 shares delivered in this transaction, relative to 7,069,000 issued shares as of the end of the month preceding the relevant month (approximately 1.28%)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise of the 15th stock acquisition rights issued through a third-party allotment (with an option to revise the exercise price) |
| Number of shares to be issued or disposed of | 90,500 new shares (32,500 shares on 19 March, 38,000 shares on 23 March and 20,000 shares on 24 March) |
| Intended allottee | Cantor Fitzgerald Europe (the allottee of these stock acquisition rights) |
| Dilution Rate | 90,500 shares delivered in this transaction, relative to 7,069,000 issued shares as of the end of the month preceding the relevant month (approximately 1.28%) |
| Total number of issued shares | 7,069,000 shares (as of the end of the month preceding the relevant month) → 7,159,500 shares (after the delivery in this transaction, simply reflecting the increase excluding treasury shares) |
| Exercise price | ¥741 (19 March, 23 March and 24 March). Details of the adjustment provisions and the floor: not disclosed |
| Number of Stock Acquisition Rights | 8,144 total issued, 905 exercised since the previous disclosure, and 1,965 unexercised as of the present date |
| Most recent equity financing | Timing 26 December 2025 / Type Issuance of the 15th stock acquisition rights (with an option to revise the exercise price) / Amount Not disclosed |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the substantial exercise of these stock acquisition rights between 19 March 2026 and 24 March 2026.